Vistin Pharma ASA (VISTN) — Capital Reinvestment Ratio
Vistin Pharma ASA (VISTN) has a Capital Reinvestment Ratio of 0.16x as of December 2025, meaning it reinvests 0% of its operating cash flow (Nkr40.81 Million) in capital expenditures (Nkr6.51 Million). Check tangible equity quality of Vistin Pharma ASA to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Vistin Pharma ASA Capital Reinvestment Ratio (2016–2025)
This chart tracks Vistin Pharma ASA's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see Vistin Pharma ASA (VISTN) cash conversion ratio.
Annual Capital Reinvestment Ratio for Vistin Pharma ASA (2016–2025)
Year-by-year Capital Reinvestment Ratio for Vistin Pharma ASA from 2016 to 2025. See VISTN free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | Nkr78.04 Million | Nkr16.68 Million | ▼ -43.5% |
| 2024 | 0.38x | Nkr107.86 Million | Nkr40.80 Million | ▲ +91.5% |
| 2023 | 0.20x | Nkr90.59 Million | Nkr17.90 Million | ▼ -91.5% |
| 2021 | 2.33x | Nkr13.68 Million | Nkr31.94 Million | ▲ +140.8% |
| 2019 | 0.97x | Nkr18.93 Million | Nkr18.36 Million | ▼ -74.1% |
| 2017 | 3.74x | Nkr9.51 Million | Nkr35.55 Million | ▲ +1136.9% |
| 2016 | 0.30x | Nkr53.84 Million | Nkr16.27 Million | — |